Cardiovascular Drugs Global Market Report 2018

Starting Price : $ 4000.00 | Pages : 125 | Published : February 2018 | SKU CODE : 3250 | Format :

Cardiovascular drugs market covers the drugs used to treat conditions that affect the heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anti-hypertensive drugs such as calcium channel blockers and Angiotensin II receptor antagonists, and hypolipidemic drugs such as fibric acid derivatives and bile acid binding resins.

The top five companies covered are Merck & Co., Sanofi S.A., Pfizer Inc., Bristol-Myers Squibb Company and Novartis AG. Merck & Co. was the largest company in the cardiovascular drugs market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

Cardiovascular Drugs Global Market Size

The global cardiovascular drugs market was valued at around $129 billion in 2017. North America was the largest region in the cardiovascular drugs market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for nearly 25% market share.

Cardiovascular Drugs Global Market Trend

The innovation of gene testing technologies for the development of personalized medicine for cardiovascular diseases is one of the major trends in the market. Due to the reduction in the cost of gene testing, patients can screen for their predisposition for specific cardiovascular diseases. Gene testing helps in the development of personalized pharmacogenomic agents and improved patient monitoring efforts for cardiovascular disorders and detect them before an onset of acute care episodes.

Cardiovascular Drugs Global Market Segmentation

The cardiovascular drugs market is segmented into Anti-Hypertensive Drugs, Hypolipidemic Drugs, Antithrombotics Drugs and Other (Congestive Heart Failure, Antiarrhythmic and Antianginal) Drugs.
Anti-Hypertensive Drugs are used to prevent heart failure, kidney failure and acute stroke induced by hypertension. These companies also offer drugs to control blood pressure and delay the development of atherosclerosis.
Hypolipidemic Drugs are those drugs that lower lipid and lipoproteins levels in the blood.
Antithrombotics Drugs are used to prevent and treat arterial and venous thrombosis.
Other (Congestive Heart Failure, Antiarrhythmic and Antianginal) Drugs are the drugs that prevent congestive heart failure, drugs used for the treatment of cardiovascular diseases, antiarrhythmic drugs used for the treatment of abnormal heart rhythms, and antianginal drugs used for angina management.

Cell-free DNA Genetic Screening To Detect Problems in Pregnancy
CAPS: A Trend In Anesthesia To Perform Surgeries Under Sedation
EHRs Have Made It Easy For Cardiologists To Treat Their Patients
Therapy For Photo Damaged Skin: Daylight PDT
Digital Psychotherapy- Shorten The Distance Between Psychiatrists And People From Remote Areas
Virtual Mental Health Treatment Facilities To Maintain Anonymity
Mental Health Software For Keeping Medical Records!
Healthcare Services Now More Efficient And Cost Effective With Digitization!
Podiatry Services Global Market Strategies and Opportunities to 2021
View Report
Global Minor Orthopedic Implants Replacement Market, Opportunities And Strategies To 2021
View Report
Global Biologics Market, Opportunities And Strategies To 2021
View Report
Global Pharmaceutical Drugs Market, Opportunities And Strategies To 2021
View Report
Global Diabetes Test Strips Market, Opportunities And Strategies To 2021
View Report
Global Veterinary Services Market, Opportunities And Strategies To 2021
View Report
Global Podiatry Services Market, Opportunities And Strategies To 2021
View Report
Global Major Orthopedic Joint Replacement Implants Market, Opportunities And Strategies To 2022
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)